Sickle Cell - pain man

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/7

encourage image

There's no tags or description

Looks like no tags are added yet.

8 Terms

1
New cards

Describe the general pathophysiology of sickle cell disease and explain how it contributes to common clinical presentations and complications.

Pathophysiology 

  • Normal RBCs

    • Biconcave, disc-shaped, flexible

    • Transport oxygen throughout the body

  • Sickle Cell Disease (SCD)

    • Abnormal hemoglobin (HbS) polymerizes when deoxygenated

    • RBCs become sickle-shaped, rigid, and fragile

Clinical Presentation 

  • First symptoms include pain and swelling of the hands and feet, commonly referred to as hand-and-foot syndrome or dactylitis in infants

  • Laboratory findings:

    • Low hemoglobin level (6 to 9 g/dL)

    • Elevated reticulocytes of 10% to 25%

    • Elevated lactate dehydrogenase

    • Elevated platelet count

    • Elevated white blood cell (WBC) count

    • Normal MCV


Complications


2
New cards

Identify the common triggers, presentation, and risk factors associated with pain in sickle cell disease → most common reason for seeking treatment 

  • Cause:

    • Microvascular occlusion in the bone marrow

  • Common Triggers:

    • Fever, infections, dehydration, hypoxia, acidosis, sudden temperature alterations 

  • Characteristics:

    • Continuous, throbbing, localized or migratory

  • Common Locations:

    • Back, chest, and extremities 

  • Other risk factors:

    • Older age, iron overload, low HbF (fetal hemoglobin) levels



Treatment:

  • Penicillin prophylaxis

  • Hydroxyurea

  • L-glutamine

  • Crizanlizumab

  • Chronic transfusion therapy

    • Primarily for stroke prevention

  • Allogeneic Hematopoietic Cell Transplantation (curative)

  • Gene therapies for SCD: exagamglogene autotemcel and lovotibeglogene autotemcel


3
New cards

Hydroxyurea

  • MOA: stimulates fetal hemoglobin (HbF) production and increases the number of HbF-containing reticulocytes and intracellular HbF

    • Higher HbF decreased RBC sickling and adhesion

  • Benefits: reduces the frequency of painful episodes, risk of ACS, need for blood transfusions, and number of hospitalizations

  • ADRs: bone marrow suppression (neutropenia, thrombocytopenia, anemia), dry skin, hyperpigmentation of skin or nails

  • Risk for teratogenicity based on animal studies

  • Monitoring

    • Absolute neutrophil count (ANC), platelets, hemoglobin, reticulocyte count

    • SCr

    • LFTs


4
New cards

L-glutamine

  • MOA:

    • Glutamine is an essential amino acid and precursor for nicotinamide adenine dinucleotide (NAD+) synthesis

    • Increased NAD+ can restore balance in oxidatively stressed cells

  • Benefits: reduced pain and hospitalizations

  • ADRs: well-tolerated, nausea, constipation, abdominal pain, noncardiac chest pain, fatigue, and musculoskeletal pain


5
New cards

Treatment of Sickle Cell Pain: Acute


6
New cards

Non-pharm for acute pain (in addition to pharm)

massage, yoga, transcutaneous electrical nerve stimulation (TENS), virtual reality (VR), guided audiovisual (AV) relaxation

7
New cards

Treatment of Chronic Sickle Cell Pain

  • Chronic pain due to avascular necrosis of bone

    • Duloxetine (and other SNRIs)

    • NSAIDs

  • Chronic pain with unknown cause

    • SNRIs

    • TCAs

    • Gabapentinoids

  • Guidelines recommend AGAINST chronic opioid therapy unless pain is refractory to multiple other treatment modalities

    • If used, follow CDC guideline recommendations.

  • Guidelines recommend AGAINST chronic monthly transfusion therapy 


8
New cards

Treatment of Chronic Sickle Cell Pain → nonpharm (in addition to pharm)

cognitive behavioral therapy (CBT)-most preferred, acceptance and commitment therapy (ACT), mindfulness-based treatments, acupuncture, massage